306935-96-6 Usage
Uses
Used in Organic Synthesis:
5-[3-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is used as a building block in organic synthesis for the creation of various other organic compounds. Its unique structure and functional groups make it a versatile component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In pharmaceutical research, 5-[3-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is used as a starting material for the synthesis of potential drug candidates. Its potential biological activities and the impact of the trifluoromethoxy group on its properties make it a promising candidate for the development of new pharmaceuticals.
Used in Chemical Applications:
5-[3-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is also used in various chemical applications due to the significant influence of the trifluoromethoxy group on its chemical and physical properties. This makes it a valuable tool in the development of new chemical products and technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 306935-96-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,6,9,3 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 306935-96:
(8*3)+(7*0)+(6*6)+(5*9)+(4*3)+(3*5)+(2*9)+(1*6)=156
156 % 10 = 6
So 306935-96-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H7F3O3/c13-12(14,15)18-9-3-1-2-8(6-9)11-5-4-10(7-16)17-11/h1-7H
306935-96-6Relevant articles and documents
Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid
Pfefferkorn, Jeffrey A.,Greene, Meredith L.,Nugent, Richard A.,Gross, Rebecca J.,Mitchell, Mark A.,Finzel, Barry C.,Harris, Melissa S.,Wells, Peter A.,Shelly, John A.,Anstadt, Robert A.,Kilkuskie, Robert E.,Kopta, Laurice A.,Schwende, Francis J.
, p. 2481 - 2486 (2007/10/03)
A novel series of nonnucleoside HCV NS5B polymerase inhibitors were prepared from (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid, a high throughput screening lead. SAR studies combined with structure based drug design focusing on the southern heterobiaryl region of the template led to the synthesis of several potent and orally bioavailable lead compounds. X-ray crystallography studies were also performed to understand the interaction of these inhibitors with HCV NS5B polymerase.